zSpace (ZSPC) Competitors

Shuttle Pharmaceuticals has lower revenue, but higher earnings than zSpace. Shuttle Pharmaceuticals is trading at a lower price-to-earnings ratio than zSpace, indicating that it is currently the more affordable of the two stocks.

Shuttle Pharmaceuticals has a net margin of 0.00% compared to zSpace's net margin of -91.13%. zSpace's return on equity of 0.00% beat Shuttle Pharmaceuticals' return on equity.

zSpace currently has a consensus price target of $100.00, suggesting a potential upside of 45,189.86%. Given zSpace's stronger consensus rating and higher possible upside, analysts clearly believe zSpace is more favorable than Shuttle Pharmaceuticals.

4.6% of Shuttle Pharmaceuticals shares are owned by institutional investors. 8.7% of zSpace shares are owned by company insiders. Comparatively, 1.3% of Shuttle Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

zSpace has a beta of -1.47, meaning that its share price is 247% less volatile than the broader market. Comparatively, Shuttle Pharmaceuticals has a beta of 0.21, meaning that its share price is 79% less volatile than the broader market.

In the previous week, Shuttle Pharmaceuticals had 2 more articles in the media than zSpace. MarketBeat recorded 2 mentions for Shuttle Pharmaceuticals and 0 mentions for zSpace. Shuttle Pharmaceuticals' average media sentiment score of 1.44 beat zSpace's score of 0.00 indicating that Shuttle Pharmaceuticals is being referred to more favorably in the news media.

zSpace presently has a consensus price target of $100.00, indicating a potential upside of 45,189.86%. Banzai International has a consensus price target of $42.00, indicating a potential upside of 2,098.95%. Given zSpace's higher possible upside, equities research analysts plainly believe zSpace is more favorable than Banzai International.

Banzai International has lower revenue, but higher earnings than zSpace. Banzai International is trading at a lower price-to-earnings ratio than zSpace, indicating that it is currently the more affordable of the two stocks.

In the previous week, Banzai International had 2 more articles in the media than zSpace. MarketBeat recorded 2 mentions for Banzai International and 0 mentions for zSpace. Banzai International's average media sentiment score of 0.63 beat zSpace's score of 0.00 indicating that Banzai International is being referred to more favorably in the news media.

zSpace has a beta of -1.47, suggesting that its share price is 247% less volatile than the broader market. Comparatively, Banzai International has a beta of -1, suggesting that its share price is 200% less volatile than the broader market.

96.8% of Banzai International shares are owned by institutional investors. 8.7% of zSpace shares are owned by company insiders. Comparatively, 2.8% of Banzai International shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

zSpace has a net margin of -91.13% compared to Banzai International's net margin of -237.54%. zSpace's return on equity of 0.00% beat Banzai International's return on equity.

zSpace currently has a consensus price target of $100.00, suggesting a potential upside of 45,189.86%. Given zSpace's stronger consensus rating and higher possible upside, equities analysts clearly believe zSpace is more favorable than Wellchange.

In the previous week, Wellchange had 4 more articles in the media than zSpace. MarketBeat recorded 4 mentions for Wellchange and 0 mentions for zSpace. Wellchange's average media sentiment score of 0.47 beat zSpace's score of 0.00 indicating that Wellchange is being referred to more favorably in the news media.

zSpace has a beta of -1.47, suggesting that its share price is 247% less volatile than the broader market. Comparatively, Wellchange has a beta of 2.71, suggesting that its share price is 171% more volatile than the broader market.

Wellchange has lower revenue, but higher earnings than zSpace.

Wellchange has a net margin of 0.00% compared to zSpace's net margin of -91.13%.

Youxin Technology has lower revenue, but higher earnings than zSpace.

In the previous week, Youxin Technology had 1 more articles in the media than zSpace. MarketBeat recorded 1 mentions for Youxin Technology and 0 mentions for zSpace. Youxin Technology's average media sentiment score of 1.87 beat zSpace's score of 0.00 indicating that Youxin Technology is being referred to more favorably in the news media.

zSpace presently has a consensus price target of $100.00, suggesting a potential upside of 45,189.86%. Given zSpace's stronger consensus rating and higher probable upside, equities analysts plainly believe zSpace is more favorable than Youxin Technology.

Youxin Technology has a net margin of 0.00% compared to zSpace's net margin of -91.13%.

zSpace has a beta of -1.47, suggesting that its share price is 247% less volatile than the broader market. Comparatively, Youxin Technology has a beta of 1.84, suggesting that its share price is 84% more volatile than the broader market.